Visitor Monitoring Drug History: ZERIT
 
Drugs Directory of False Positives DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST
 
Browse by Letter: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Label and Approval History

Drug Name: ZERIT
FDA Application No: (NDA) 020413
Active Ingredient(s): STAVUDINE
Company: BRISTOL MYERS SQUIBB
 
Label History
 
View the label approved on February 5, 2007 for ZERIT, (NDA) 020413


To see older, previously-approved labels, go to the "Approval History" section of this page. Older labels are for historical information only and should not be used for clinical purposes.
 
 
 
Approval History
 
Action DateSupplement NumberSort imageApproval TypeLetters, Reviews, Labels, Patient Package Insert
4/20/2007 018Labeling Revision Letter
Letter 
6/6/2007 018Labeling Revision Letter
Letter 
6/13/2007 018Labeling Revision Letter
Letter 
6/21/2007 018Labeling Revision Letter
Letter 
12/20/2005 015Labeling Revision Label 
6/4/2004 014Labeling Revision Letter
Label 
2/20/2002 009Labeling Revision Letter 
2/20/2002 008Labeling Revision Letter 
3/29/2002 007Efficacy Supplement with Clinical Data to Support Letter
Label 
10/16/2001 006Labeling Revision Label 
9/27/2000 005Labeling Revision  
9/16/1998 004Labeling Revision  
7/1/1999 003New or Modified Indication  
8/19/1998 002Control Supplement  
2/4/1998 001Labeling Revision  
9/6/1996 000Approval  
 
Therapeutic Equivalents
©2019 Drugs That Causes a False Positive on a Drug Test